Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417391 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ekaterina Bezverkhniaia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Research Council, Uppsala University.
Abstract (Originalsprache)
Radionuclide imaging using radiolabeled inhibitors of prostate-specific membrane antigen (PSMA) can be used for the staging of prostate cancer. Previously, we optimized the Glu-urea-Lys binding moiety using a linker structure containing 2-napththyl-L-alanine and L-tyrosine. We have now designed a molecule that contains mercaptoacetyl–triglutamate chelator for labeling with Tc-99m (designated as BQ0413). The purpose of this study was to evaluate the imaging properties of [99mTc]Tc-BQ0413. PSMA-transfected PC3-pip cells were used to evaluate the specificity and affinity of [99mTc]Tc-BQ0413 binding in vitro. PC3-pip tumor-bearing BALB/C nu/nu mice were used as an in vivo model. [99mTc]Tc-BQ0413 bound specifically to PC3-pip cells with an affinity of 33 ± 15 pM. In tumor-bearing mice, the tumor uptake of [99mTc]Tc-BQ0413 (38 ± 6 %IA/g in PC3-pip 3 h after the injection of 40 pmol) was dependent on PSMA expression (3 ± 2 %IA/g and 0.9 ± 0.3 %IA/g in PSMA-negative PC-3 and SKOV-3 tumors, respectively). We show that both unlabeled BQ0413 and the commonly used binder PSMA-11 enable the blocking of [99mTc]Tc-BQ0413 uptake in normal PSMA-expressing tissues without blocking the uptake in tumors. This resulted in an appreciable increase in tumor-to-organ ratios. At the same injected mass (5 nmol), the use of BQ0413 was more efficient in suppressing renal uptake than the use of PSMA-11. In conclusion, [99mTc]Tc-BQ0413 is a promising probe for the visualization of PSMA-positive lesions using single-photon emission computed tomography (SPECT).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden.
- Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634009 Tomsk, Russia.
- Scientific and Research Laboratory of Chemical and Pharmaceutical Research, Siberian State Medical University, 634050 Tomsk, Russia.
- Department of Immunology, Genetics and Pathology, Uppsala University, 752 37 Uppsala, Sweden.
- Affibody AB, 171 65 Solna, Sweden.
- Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.
ORCID-Profile: Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Mariia Larkina, Maryam Oroujeni, Anzhelika Vorobyeva, Ulrika Rosenström, Vladimir Tolmachev, Anna Orlova
Förderung
- Swedish Cancer Society
- Swedish Research Council
- Uppsala University
- Tomsk Polytechnic University
Zitieren
APA
Bezverkhniaia, E., Kanellopoulos, P., Abouzayed, A., Larkina, M., Oroujeni, M., Vorobyeva, A., Rosenström, U., Tolmachev, V., & Orlova, A. (2023). Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417391
Vancouver
Bezverkhniaia E, Kanellopoulos P, Abouzayed A, Larkina M, Oroujeni M, Vorobyeva A, et al. Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA). International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417391
BibTeX
@article{Bezverkhniaia2023,
author = {Bezverkhniaia, Ekaterina and Kanellopoulos, Panagiotis and Abouzayed, Ayman and Larkina, Mariia and Oroujeni, Maryam and Vorobyeva, Anzhelika and Rosenström, Ulrika and Tolmachev, Vladimir and Orlova, Anna},
title = {Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417391}
}
EUVIMED